Immunogenicity and safety of beta variant COVID-19 vaccine AZD2816 and AZD1222 (ChAdOx1 nCoV-19) as primary-series vaccination for previously unvaccinated adults in Brazil, South Africa, Poland, and the UK: a randomised, partly double-blinded, phase 2/3 non-inferiority immunobridging study
-
Published:2024-08
Issue:8
Volume:5
Page:100863
-
ISSN:2666-5247
-
Container-title:The Lancet Microbe
-
language:en
-
Short-container-title:The Lancet Microbe
Author:
Costa Clemens Sue Ann, Jepson Brett, Bhorat Qasim E, Ahmad AbdullahiORCID, Akhund Tauseefullah, Aley Parvinder K, Bansal Himanshu, Bibi Sagida, Kelly Elizabeth J, Khan Mark, Lambe Teresa, Lombaard Johan J, Matthews Sam, Pipolo Milan Eveline, Olsson Urban, Ramasamy Maheshi N, Moura de Oliveira Paiva Maria Sanali, Seegobin Seth, Shoemaker Kathryn, Szylak Ameena, Villafana Tonya, Pollard Andrew J, Green Justin AORCID, de Oliveira Paiva Hugo Diógenes, Smith Catherin C, Brites Carlos, Sprinz Eduardo, Vasconcellos Eduardo, Badal-Faesen Sharlaa, Koen Anthonet, Burgess Lesley, Engelbrecht Johannes, Vekemans Johan, Kobielusz-Gembala Iwona, Jones Colin, Hirsch Ian, Aksyuk Anastasia, Wilkins Deidre, Stanely Ann Marie, Petropoulos Christos J, Wrin Terri, Rugieri Sidelcina, Bennet Jaclyn A, Greffrath Johann, Sorio Guilherme L, Mantyka Jolanta
Reference24 articles.
1. SARS-CoV-2 variant biology: immune escape, transmission and fitness;Carabelli;Nat Rev Microbiol,2023 2. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study;Watson;Lancet Infect Dis,2022 3. COVID-19 vaccine effectiveness against the omicron (B.1.1.529) variant;Andrews;N Engl J Med,2022 4. Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study;Costa Clemens;Lancet,2022 5. Heterologous third and fourth dose vaccines reduce severity and mortality in COVID-19 patients during the periods of delta and omicron predominance in Thailand;Intawong;Int J Infect Dis,2022
|
|